May 2018 Portfolio Company Update: New Investments, New Headlines
The newest OIF portfolio companies are already making waves in their respective industries, markets
Since the beginning of 2018, Ohio Innovation Fund has brought two additional startups to its already impressive roster of innovative companies. These two startups, ConnXus and Genetesis, have made their way into the national spotlight this past month, while Immuta continues to rapidly expand its industry-wide, international influence.
Take a look at just some of the most recent news from our extraordinary portfolio companies.
Genetesis & Enable Injections Make Cincinnati a Better Place
Inc.com recently published an article highlighting all of the great things Cincinnati has to offer new businesses. From easy access to startup capital, to a blossoming business community/network, to the area’s wealth of natural talent and entertainment options, the Queen City is quickly becoming a Midwest economic powerhouse. The article highlights successful startups, including OIF portfolio companies Genetesis and Enable Injections, as evidence of the city’s influence and potential.
Explore why Cincinnati is the perfect location for your next business venture.
Switch It Up: ConnXus COO & General Manager Featured in Procurement Magazine
In the world of supply management, diversifying the supply chain can result in decreased costs, lowered risks and increased downstream economic stimulation. Daryl Hammett of ConnXus recently wrote a guest article for Procurement Leaders discussing the benefits of a diverse supply base.
“Diverse businesses can also impact your bottom line. Many have to be nimble and agile to compete. They have to be innovative and must design creative solutions to make more from less. The nature of these businesses is to drive down costs but add value.”
Immuta’s International Data Security Influence & the Impact of GDPR
See what the experts have to say regarding GDPR risks for investors.